131 related articles for article (PubMed ID: 21419474)
41. Diagnostic laparoscopy, serum CA125, and peritoneal metastasis in gastric cancer.
Fujimura T; Kinami S; Ninomiya I; Kitagawa H; Fushida S; Nishimura G; Kayahara M; Shimizu K; Ohta T; Miwa K
Endoscopy; 2002 Jul; 34(7):569-74. PubMed ID: 12170412
[TBL] [Abstract][Full Text] [Related]
42. Serum vascular endothelial growth factor-C combined with multi-detector CT in the preoperative diagnosis of lymph node metastasis of gastric cancer.
Wang TB; Wang J; Wei XQ; Wei B; Dong WG
Asia Pac J Clin Oncol; 2012 Jun; 8(2):180-6. PubMed ID: 22524577
[TBL] [Abstract][Full Text] [Related]
43. Identification of matrix metalloproteinase 11 as a predictive tumor marker in serum based on gene expression profiling.
Yang YH; Deng H; Li WM; Zhang QY; Hu XT; Xiao B; Zhu HH; Geng PL; Lu YY
Clin Cancer Res; 2008 Jan; 14(1):74-81. PubMed ID: 18172255
[TBL] [Abstract][Full Text] [Related]
44. Suppression of selenium-binding protein 1 in gastric cancer is associated with poor survival.
Xia YJ; Ma YY; He XJ; Wang HJ; Ye ZY; Tao HQ
Hum Pathol; 2011 Nov; 42(11):1620-8. PubMed ID: 21497372
[TBL] [Abstract][Full Text] [Related]
45. Prognostic value of sonic hedgehog protein expression in gastric cancer.
Kim JY; Ko GH; Lee YJ; Ha WS; Choi SK; Jung EJ; Jeong CY; Ju YT; Jeong SH; Hong SC
Jpn J Clin Oncol; 2012 Nov; 42(11):1054-9. PubMed ID: 22941587
[TBL] [Abstract][Full Text] [Related]
46. Expression of stanniocalcin 1 as a potential biomarker of gastric cancer.
Arigami T; Uenosono Y; Ishigami S; Hagihara T; Haraguchi N; Matsushita D; Yanagita S; Nakajo A; Okumura H; Hokita S; Natsugoe S
Oncology; 2012; 83(3):158-64. PubMed ID: 22889960
[TBL] [Abstract][Full Text] [Related]
47. S100A9, GIF and AAT as potential combinatorial biomarkers in gastric cancer diagnosis and prognosis.
Wu W; Juan WC; Liang CR; Yeoh KG; So J; Chung MC
Proteomics Clin Appl; 2012 Apr; 6(3-4):152-62. PubMed ID: 22532451
[TBL] [Abstract][Full Text] [Related]
48. Serum hepatocyte growth factor as a prognostic marker for stage II or III colorectal cancer patients.
Toiyama Y; Miki C; Inoue Y; Okugawa Y; Tanaka K; Kusunoki M
Int J Cancer; 2009 Oct; 125(7):1657-62. PubMed ID: 19569242
[TBL] [Abstract][Full Text] [Related]
49. REG4 promotes peritoneal metastasis of gastric cancer through GPR37.
Wang H; Hu L; Zang M; Zhang B; Duan Y; Fan Z; Li J; Su L; Yan M; Zhu Z; Liu B; Yang Q
Oncotarget; 2016 May; 7(19):27874-88. PubMed ID: 27036049
[TBL] [Abstract][Full Text] [Related]
50. Coordinated expression of REG4 and aldehyde dehydrogenase 1 regulating tumourigenic capacity of diffuse-type gastric carcinoma-initiating cells is inhibited by TGF-β.
Katsuno Y; Ehata S; Yashiro M; Yanagihara K; Hirakawa K; Miyazono K
J Pathol; 2012 Nov; 228(3):391-404. PubMed ID: 22430847
[TBL] [Abstract][Full Text] [Related]
51. [Expression of aldo-keto reductase family 1 member B10 in gastric cancer tissues and its clinical significance].
Yao HB; Xu Y; Chen LG; Guan TP; Ma YY; Tao HQ; Shao QS
Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Feb; 16(2):183-7. PubMed ID: 23446484
[TBL] [Abstract][Full Text] [Related]
52. Serum tumor antigen REG4 as a diagnostic biomarker in pancreatic ductal adenocarcinoma.
Takayama R; Nakagawa H; Sawaki A; Mizuno N; Kawai H; Tajika M; Yatabe Y; Matsuo K; Uehara R; Ono K; Nakamura Y; Yamao K
J Gastroenterol; 2010; 45(1):52-9. PubMed ID: 19789838
[TBL] [Abstract][Full Text] [Related]
53. Methylated TIMP-3 DNA in body fluids is an independent prognostic factor for gastric cancer.
Yu JL; Lv P; Han J; Zhu X; Hong LL; Zhu WY; Wang XB; Wu YC; Li P; Ling ZQ
Arch Pathol Lab Med; 2014 Nov; 138(11):1466-73. PubMed ID: 25357107
[TBL] [Abstract][Full Text] [Related]
54. Clinical Significance of Serum p53 Antibody in the Early Detection and Poor Prognosis of Gastric Cancer.
Kunizaki M; Fukuda A; Wakata K; Tominaga T; Nonaka T; Miyazaki T; Matsumoto K; Sumida Y; Hidaka S; Yasutake T; Sawai T; Hamamoto R; Nanashima A; Nagayasu T
Anticancer Res; 2017 Apr; 37(4):1979-1984. PubMed ID: 28373470
[TBL] [Abstract][Full Text] [Related]
55. A novel screening biomarker in gastric cancer: serum Dickkopf-1.
Gomceli I; Bostanci EB; Ozer I; Kemik AS; Turhan N; Tez M; Kilic S; Demiriz B; Akoglu M
Hepatogastroenterology; 2012; 59(117):1661-4. PubMed ID: 22155860
[TBL] [Abstract][Full Text] [Related]
56. Serum CA 19-9 as a prognostic factor in patients with metastatic gastric cancer.
Jo JC; Ryu MH; Koo DH; Ryoo BY; Kim HJ; Kim TW; Choi KD; Lee GH; Jung HY; Yook JH; Oh ST; Kim BS; Kim JH; Kang YK
Asia Pac J Clin Oncol; 2013 Dec; 9(4):324-30. PubMed ID: 23176400
[TBL] [Abstract][Full Text] [Related]
57. Clinical significance of serum and tissue Dickkopf-1 levels in patients with gastric cancer.
Lee HS; Lee HE; Park DJ; Kim HH; Kim WH; Park KU
Clin Chim Acta; 2012 Nov; 413(21-22):1753-60. PubMed ID: 22796372
[TBL] [Abstract][Full Text] [Related]
58. Detection of vimentin methylation in the serum of patients with gastric cancer.
Shirahata A; Sakuraba K; Kitamura Y; Yokomizo K; Gotou T; Saitou M; Kigawa G; Nemoto H; Sanada Y; Hibi K
Anticancer Res; 2012 Mar; 32(3):791-4. PubMed ID: 22399595
[TBL] [Abstract][Full Text] [Related]
59. Soluble E-cadherin is a valid prognostic marker in gastric carcinoma.
Chan AO; Lam SK; Chu KM; Lam CM; Kwok E; Leung SY; Yuen ST; Law SY; Hui WM; Lai KC; Wong CY; Hu HC; Lai CL; Wong J
Gut; 2001 Jun; 48(6):808-11. PubMed ID: 11358900
[TBL] [Abstract][Full Text] [Related]
60. Serum-soluble interleukin-2 receptor concentrations in patients with gastric cancer.
Murakami S; Satomi A; Ishida K; Murai H; Matsuki M; Hashimoto T
Cancer; 1994 Nov; 74(10):2745-8. PubMed ID: 7525035
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]